These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10170301)

  • 1. The effects of clonazepam on quality of life and work productivity in panic disorder.
    Jacobs RJ; Davidson JR; Gupta S; Meyerhoff AS
    Am J Manag Care; 1997 Aug; 3(8):1187-96. PubMed ID: 10170301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care.
    Rollman BL; Belnap BH; Mazumdar S; Houck PR; Zhu F; Gardner W; Reynolds CF; Schulberg HC; Shear MK
    Arch Gen Psychiatry; 2005 Dec; 62(12):1332-41. PubMed ID: 16330721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G
    Arthritis Rheum; 1999 Sep; 42(9):1870-8. PubMed ID: 10513801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.
    Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G
    J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal studies of clonazepam in panic disorder.
    Davidson JR; Moroz G
    Psychopharmacol Bull; 1998; 34(2):169-74. PubMed ID: 9640996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder.
    Worthington JJ; Pollack MH; Otto MW; McLean RY; Moroz G; Rosenbaum JF
    Psychopharmacol Bull; 1998; 34(2):199-205. PubMed ID: 9641001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.
    Nardi AE; Valença AM; Nascimento I; Lopes FL; Mezzasalma MA; Freire RC; Veras AB; Zin WA; Versiani M
    Psychiatry Res; 2005 Nov; 137(1-2):61-70. PubMed ID: 16226812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
    J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
    Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
    J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
    Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
    Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial.
    Allgulander C; Jørgensen T; Wade A; François C; Despiegel N; Auquier P; Toumi M
    Curr Med Res Opin; 2007 Oct; 23(10):2543-9. PubMed ID: 17825130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G; Rosenbaum JF
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in early phases of panic disorder: predictive factors.
    Carrera M; Herrán A; Ayuso-Mateos JL; Sierra-Biddle D; Ramírez ML; Ayestarán A; Hoyuela F; Rodríguez-Cabo B; Vázquez-Barquero JL
    J Affect Disord; 2006 Aug; 94(1-3):127-34. PubMed ID: 16762421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.
    Ehrich EW; Bolognese JA; Watson DJ; Kong SX
    Am J Manag Care; 2001 Jun; 7(6):609-16. PubMed ID: 11439734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
    Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M
    J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
    Kelleher CJ; Cardozo L; Chapple CR; Haab F; Ridder AM
    BJU Int; 2005 Jan; 95(1):81-5. PubMed ID: 15638900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.